Peter Heerma, Chief Commercial Officer at Travere Therapeutics, Inc. (TVTX), sold 6,084 shares at $25.68 ($156K) on 2022-10-04, disclosed to the SEC on 2022-10-06.
Open-market sale of $156k TVTX by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.68 | 3,042 | $78K | 50.0% |
| 2 | $25.68 | 3,042 | $78K | 50.0% |
| Total | $25.68 avg | 6,084 | $156K | 100% |
| Filing → |
| TVTX | SELL | 2026-04-15 | $303K | — | Filing → |
| TVTX | SELL | 2026-02-03 | $235K | — | Filing → |
| TVTX | SELL | 2025-12-29 | $199K | — | Filing → |